Trial Details
COMPLETEDBasic Information
| Clinical ID | c684 |
|---|---|
| Identifier | NCT06223685 |
| Trial Title | The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome|Small Intestinal Bacterial Overgrowth|SIBO |
| Interventions | DRUG: Rifaximin (Xifaxan) 1200mg/day|DIETARY_SUPPLEMENT: Probiotic|DRUG: XIFAXAN® (Rifaximin) 1600mg/day |
Participant Information
| Sponsor | Pomeranian Medical University Szczecin |
|---|---|
| City | West Pomeranian Voivodeship |
| Country/Region | Poland |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2023-04-01 |
|---|---|
| Primary Completion Date | 2024-08-01 |
| Completion Date | 2025-08-30 |